Vineet Laboratories Limited (VINEETLAB) - Net Assets
Based on the latest financial reports, Vineet Laboratories Limited (VINEETLAB) has net assets worth Rs142.21 Million INR (≈ $1.54 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs906.45 Million ≈ $9.80 Million USD) and total liabilities (Rs764.24 Million ≈ $8.26 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible net worth ratio of Vineet Laboratories Limited to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs142.21 Million |
| % of Total Assets | 15.69% |
| Annual Growth Rate | 148.73% |
| 5-Year Change | -44.96% |
| 10-Year Change | N/A |
| Growth Volatility | 2379.81 |
Vineet Laboratories Limited - Net Assets Trend (2017–2025)
This chart illustrates how Vineet Laboratories Limited's net assets have evolved over time, based on quarterly financial data. See Vineet Laboratories Limited liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Vineet Laboratories Limited (2017–2025)
The table below shows the annual net assets of Vineet Laboratories Limited from 2017 to 2025. For live valuation and market cap data, see market cap of Vineet Laboratories Limited.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | Rs146.48 Million ≈ $1.58 Million |
-57.82% |
| 2024-03-31 | Rs347.24 Million ≈ $3.76 Million |
+3.09% |
| 2023-03-31 | Rs336.83 Million ≈ $3.64 Million |
+1.40% |
| 2022-03-31 | Rs332.18 Million ≈ $3.59 Million |
+24.81% |
| 2021-03-31 | Rs266.15 Million ≈ $2.88 Million |
+6572.13% |
| 2020-03-31 | Rs3.99 Million ≈ $43.14K |
-2.71% |
| 2019-03-31 | Rs4.10 Million ≈ $44.34K |
+4000.00% |
| 2018-03-31 | Rs100.00K ≈ $1.08K |
0.00% |
| 2017-03-31 | Rs100.00K ≈ $1.08K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Vineet Laboratories Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 5923700000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Rs92.19 Million | 62.94% |
| Other Comprehensive Income | Rs113.52 Million | 77.50% |
| Total Equity | Rs146.48 Million | 100.00% |
Vineet Laboratories Limited Competitors by Market Cap
The table below lists competitors of Vineet Laboratories Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Corazon Mining Ltd
AU:CZN
|
$7.29 Million |
|
Thor Energy Plc
AU:THR
|
$7.29 Million |
|
ONCODES.PREC.MED. EO-34
F:ZR8
|
$7.29 Million |
|
Sintex Plastics Technology Limited
NSE:SPTL
|
$7.29 Million |
|
Readcloud Ltd
AU:RCL
|
$7.28 Million |
|
CYL Corporation Bhd
KLSE:7157
|
$7.28 Million |
|
Torr Metals Inc
V:TMET
|
$7.28 Million |
|
Iceni Gold Ltd
AU:ICL
|
$7.28 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Vineet Laboratories Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 347,243,000 to 146,476,000, a change of -200,767,000 (-57.8%).
- Net loss of 201,910,000 reduced equity.
- Other comprehensive income decreased equity by 141,530,000.
- Other factors increased equity by 142,673,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs-201.91 Million | -137.85% |
| Other Comprehensive Income | Rs-141.53 Million | -96.62% |
| Other Changes | Rs142.67 Million | +97.4% |
| Total Change | Rs- | -57.82% |
Book Value vs Market Value Analysis
This analysis compares Vineet Laboratories Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.21x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3234.03x to 2.21x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-03-31 | Rs0.01 | Rs35.08 | x |
| 2018-03-31 | Rs0.01 | Rs35.08 | x |
| 2019-03-31 | Rs0.44 | Rs35.08 | x |
| 2020-03-31 | Rs0.43 | Rs35.08 | x |
| 2021-03-31 | Rs28.87 | Rs35.08 | x |
| 2022-03-31 | Rs36.03 | Rs35.08 | x |
| 2023-03-31 | Rs36.54 | Rs35.08 | x |
| 2024-03-31 | Rs37.53 | Rs35.08 | x |
| 2025-03-31 | Rs15.89 | Rs35.08 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Vineet Laboratories Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -137.85%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -26.92%
- • Asset Turnover: 0.79x
- • Equity Multiplier: 6.45x
- Recent ROE (-137.85%) is below the historical average (-17.88%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -2.78% | 0.00% | 609.77x | 1.00x | Rs-509.92K |
| 2021 | 6.69% | 0.73% | 2.24x | 4.09x | Rs-8.81 Million |
| 2022 | 19.98% | 3.47% | 1.43x | 4.02x | Rs33.17 Million |
| 2023 | 3.72% | 0.59% | 1.83x | 3.44x | Rs-21.16 Million |
| 2024 | 2.96% | 0.68% | 1.29x | 3.37x | Rs-24.45 Million |
| 2025 | -137.85% | -26.92% | 0.79x | 6.45x | Rs-216.56 Million |
Industry Comparison
This section compares Vineet Laboratories Limited's net assets metrics with peer companies in the Chemicals industry.
Industry Context
- Industry: Chemicals
- Average net assets among peers: $11,777,939,056
- Average return on equity (ROE) among peers: 20.61%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Vineet Laboratories Limited (VINEETLAB) | Rs142.21 Million | -2.78% | 5.37x | $7.29 Million |
| Archean Chemical Industries Limited (ACI) | $19.33 Billion | 5.53% | 0.38x | $700.22 Million |
| The Andhra Sugars Limited (ANDHRSUGAR) | $6.35 Billion | 17.21% | 1.15x | $123.89 Million |
| Bhansali Engineering Polymers Limited (BEPL) | $10.02 Billion | 17.96% | 0.10x | $288.13 Million |
| Chemplast Sanmar Limited (CHEMPLASTS) | $2.46 Billion | 7.18% | 2.72x | $384.86 Million |
| DCW Limited (DCW) | $3.75 Billion | 18.05% | 1.78x | $190.02 Million |
| Deepak Fertilizers and Petrochemicals Corporation Limited (DEEPAKFERT) | $62.54 Billion | 14.93% | 1.10x | $2.08 Billion |
| DIAMINES AND CHEMICALS ORD (BSE) (DIAMINESQ) | $210.14 Million | 44.52% | 1.62x | $26.51 Million |
| DMCC SPECIALITY CHEMICALS LIMITED (DMCC) | $1.98 Billion | 3.50% | 1.02x | $67.27 Million |
| Epigral Ltd. (EPIGRAL) | $10.69 Billion | 33.05% | 1.28x | $532.76 Million |
| Foseco India Limited (FOSECOIND) | $451.96 Million | 44.18% | 0.86x | $423.21 Million |
About Vineet Laboratories Limited
Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl… Read more